12:00 AM
 | 
Jun 24, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Kineret anakinra regulatory update

Swedish Orphan said FDA approved an sBLA to allow partner Boehringer Ingelheim GmbH (Ingelheim, Germany) to manufacture the API of Kineret anakinra at its site in Vienna, Austria. The IL-1...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >